News

Bleeding events occurred substantially less often with the lower dose of aspirin, reported John Burn, MD, of Newcastle ...
Bayer submits New Drug Application (NDA) for gadoquatrane: The investigational macrocyclic gadolinium-based contrast agent is designed for contrast-enhanced MRI of the central nervous system and other ...
Medical imaging plays a significant role in clinical diagnosis, but the use of low radiation doses in CT imaging can lead to poor image resolution and precise diagnosis. In this investigation, a novel ...
Solve M.E. Selects Simmaron Research As Recipient of ME/CFS Catalyst Award to Accelerate Low-Dose Rapamycin Trial for ME/CFS, Long COVID, and IACCs By Solve M.E. Jun 17, 2025 Updated Jun 17, 2025 ...
This is a single-arm, Simon 2-stage trial. Patients with synovial sarcomas who had progressed on at least two lines were administered daily regorafenib (80/120 mg alternating once daily per orally).
This can result in side-effects like diarrhoea, vomiting, or even pancreatitis. The likelihood of the latter increases with the size of the dose, according to the professor.